When tumor sizes reached ≈100 mm3 on day 10, the mice intraperitoneally received anti‐PD‐1 (0.1 mg/0.1 mL PBS) plus anti‐4‐1BB (0.1 mg/0.1 mL PBS) antibodies 10 and 12 days after tumor implantation (Figure S5, Supporting Information).[30] On day 14, Q‐annexin V or annexin V‐Alexa647 was intravenously injected into the mice (n = 4 per group). This evidence concerns the gene TNFRSF9 and neoplasm.